175 related articles for article (PubMed ID: 27217871)
1. Serological response to Epstein-Barr virus early antigen is associated with gastric cancer and human immunodeficiency virus infection in Zambian adults: a case-control study.
Kayamba V; Monze M; Asombang AW; Zyambo K; Kelly P
Pan Afr Med J; 2016; 23():45. PubMed ID: 27217871
[TBL] [Abstract][Full Text] [Related]
2. Molecular profiling of gastric cancer in a population with high HIV prevalence reveals a shift to MLH1 loss but not the EBV subtype.
Kayamba V; Butt J; Waterboer T; Besa E; Choudhry N; Hamasuku A; Julius P; Heimburger DC; Atadzhanov M; Kelly P
Cancer Med; 2020 May; 9(10):3445-3454. PubMed ID: 32207245
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus in gastric carcinomas and gastric stump carcinomas: a late event in gastric carcinogenesis.
Zur Hausen A; van Rees BP; van Beek J; Craanen ME; Bloemena E; Offerhaus GJ; Meijer CJ; van den Brule AJ
J Clin Pathol; 2004 May; 57(5):487-91. PubMed ID: 15113855
[TBL] [Abstract][Full Text] [Related]
4. Frequency of Epstein--Barr virus infection as detected by messenger RNA for EBNA 1 in histologically proven gastric adenocarcinoma in patients presenting to a tertiary care center in South India.
Rymbai ML; Ramalingam VV; Samarasan I; Chandran BS; Mathew G; Jerobin J; Abraham AM; Sachithanandham J; Kannangai R
Indian J Med Microbiol; 2015; 33(3):369-73. PubMed ID: 26068337
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan.
Shinkura R; Yamamoto N; Koriyama C; Shinmura Y; Eizuru Y; Tokunaga M
J Med Virol; 2000 Apr; 60(4):411-6. PubMed ID: 10686024
[TBL] [Abstract][Full Text] [Related]
6. Elevated antibody titers to Epstein-Barr virus prior to the diagnosis of Epstein-Barr-virus-associated gastric adenocarcinoma.
Levine PH; Stemmermann G; Lennette ET; Hildesheim A; Shibata D; Nomura A
Int J Cancer; 1995 Mar; 60(5):642-4. PubMed ID: 7860138
[TBL] [Abstract][Full Text] [Related]
7. Circulating Antibodies against Epstein-Barr Virus (EBV) and p53 in EBV-Positive and -Negative Gastric Cancer.
Camargo MC; Kim KM; Matsuo K; Torres J; Liao LM; Morgan D; Michel A; Waterboer T; Song M; Gulley ML; Dominguez RL; Yatabe Y; Kim S; Cortes-Martinez G; Lissowska J; Zabaleta J; Pawlita M; Rabkin CS
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):414-419. PubMed ID: 31719065
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.
Ascherio A; Munger KL; Lennette ET; Spiegelman D; Hernán MA; Olek MJ; Hankinson SE; Hunter DJ
JAMA; 2001 Dec; 286(24):3083-8. PubMed ID: 11754673
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus and disease activity in multiple sclerosis.
Buljevac D; van Doornum GJ; Flach HZ; Groen J; Osterhaus AD; Hop W; van Doorn PA; van der Meché FG; Hintzen RQ
J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1377-81. PubMed ID: 16170080
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr Virus Antibody Titers Are Not Associated with Gastric Cancer Risk in East Asia.
Varga MG; Cai H; Waterboer T; Murphy G; Shimazu T; Taylor PR; Qiao YL; Park SK; Yoo KY; Jee SH; Cho ER; Kim J; Abnet CC; Tsugane S; Cai Q; Zheng W; Pawlita M; Shu XO; Epplein M
Dig Dis Sci; 2018 Oct; 63(10):2765-2772. PubMed ID: 29948559
[TBL] [Abstract][Full Text] [Related]
11. Association between
de Souza CRT; Almeida MCA; Khayat AS; da Silva EL; Soares PC; Chaves LC; Burbano RMR
World J Gastroenterol; 2018 Nov; 24(43):4928-4938. PubMed ID: 30487702
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus antibody level and gastric cancer risk in Korea: a nested case-control study.
Kim Y; Shin A; Gwack J; Ko KP; Kim CS; Park SK; Hong YC; Kang D; Yoo KY
Br J Cancer; 2009 Aug; 101(3):526-9. PubMed ID: 19550421
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and characteristics of Epstein-Barr virus-associated gastric carcinomas in Tunisia.
Trimeche M; Ksiâa F; Ziadi S; Mestiri S; Hachana M; Gacem RB; Sriha B; Korbi S
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1001-7. PubMed ID: 19491698
[TBL] [Abstract][Full Text] [Related]
14. Association of Epstein-Barr virus antibody levels with precancerous gastric lesions in a high-risk cohort.
Schetter AJ; You WC; Lennette ET; Gail MT; Rabkin CS
Cancer Sci; 2008 Feb; 99(2):350-4. PubMed ID: 18201267
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus neutralizing and early antigen antibodies in multiple sclerosis.
Lindsey JW; Hatfield LM; Vu T
Eur J Neurol; 2010 Oct; 17(10):1263-9. PubMed ID: 20402753
[TBL] [Abstract][Full Text] [Related]
16. Distribution of the Epstein-Barr virus in the normal stomach and gastric lesions in Thai population.
Wanvimonsuk S; Thitiwanichpiwong P; Keelawat S; Mutirangura A; Kitkumthorn N
J Med Virol; 2019 Mar; 91(3):444-449. PubMed ID: 30229949
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus infection in non-carcinomatous gastric epithelium.
Yanai H; Takada K; Shimizu N; Mizugaki Y; Tada M; Okita K
J Pathol; 1997 Nov; 183(3):293-8. PubMed ID: 9422984
[TBL] [Abstract][Full Text] [Related]
18. Co-infection relationship with Epstein-Barr virus in gastroduodenal diseases with Helicobacter Pylori. Quantitative PCR and EBNA-1 gene-based approach.
Akkus S; Gareayaghi N; Saribas S; Demiryas S; Ozbey D; Kepil N; Demirci M; Ziver Snap T; Oyku Dinc H; Akcin R; Uysal O; Tugberk Bakar M; Talha Aygun M; Bahar Tokman H; Kocazeybek B
Acta Gastroenterol Belg; 2022; 85(2):301-308. PubMed ID: 35709774
[TBL] [Abstract][Full Text] [Related]
19. Epstein Barr virus antibody reactivity and gastric cancer: A population-based case-control study.
Aragonés N; Fernández de Larrea N; Pastor-Barriuso R; Michel A; Romero B; Pawlita M; Mayorgas-Torralba S; Martín V; Moreno V; Casabonne D; Castilla J; Fernandez-Tardón G; Dierssen-Sotos T; Capelo R; Salas D; Salcedo-Bellido I; Chirlaque MD; Brenner N; Pedraza M; Bessa X; Pérez-Gómez B; Butt J; Kogevinas M; Del Campo R; de Sanjosé S; Waterboer T; Pollán M
Cancer Epidemiol; 2019 Aug; 61():79-88. PubMed ID: 31154081
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
Nystad TW; Myrmel H
J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
